Abstract: The present disclosure discloses a frame and a backlight source with the frame. The frame includes a long border and short borders located on two sides of the long border. The long border has a first arc-shaped structure configured such that a central position of the long border is bent inwards relative to two ends of the long border. Each of the short borders has a second arc-shaped structure configured such that two ends of the each of the short borders are bent inwards relative to a central position of the each of the short borders. First connection members for engagement with the rectangular back plate are disposed at the central position, and positions, close to the two ends, of the long border, and at the central position, and positions, close to the two ends, of each of the short borders, respectively.

Abstract: The present disclosure provides a backlight module and a display device. The backlight module includes a back plate comprising a base plate and at least one side wall defining an accommodation space, a frame, at least a portion of which is accommodated in the space. The frame comprises at least one side surface arranged opposite to the side wall. Clamping hooks are arranged on the side surface, and matching parts are arranged on the side wall and correspond with the clamping hooks. The clamping hook comprises a first portion connected to the side surface and a second portion formed by bending and extending the first portion. The matching part comprises a hook hole portion and a retainer portion arranged around the hook hole portion. The first portion may be inserted into the hook hole portion, and the second portion is clamped by and fixed with the retainer portion.

Abstract: A method for evaluation of switched reluctance motor system reliability through quantitative analysis of a three-level Markov model. Through analysis of the operating condition of switched reluctance motor drive system under first-level faults, second-level faults and third-level faults, 4 valid states and 1 invalid state under first-level faults, 14 valid states and 4 invalid states under second-level faults, and 43 valid states and 14 invalid states under third-level faults are obtained. If initial normal state and final invalid state are also considered, a three-level Markov model will have 62 valid states and 20 invalid states in total. A state transition diagram of the switched reluctance motor drive system under three-level faults is established, a state transition matrix is obtained, a probability matrix of the system in valid states is attained, the sum of all elements of the probability matrix is calculated, and MTTF is obtained from a reliability function.

Abstract: A braking torque closed-loop control system and method for a switch reluctance motor. The closed-loop control system comprises a torque regulator, a mode selector, a current regulator, an angle optimization controller and a torque estimator. On the basis of the rotating speed of the motor, the mode selector implements a phase current soft chopper control in a low rotating speed region and an angle position control in a high rotating speed region. The current regulator performs soft chopper hysteretic current regulation. The angle optimization controller optimizes a turn-on angle and a turn-off angle of a power converter master switch to reduce torque pulsation and improve braking energy feedback efficiency. The torque estimator conducts an on-line estimation of an actual braking torque estimated value of the motor based on an actual phase voltage and current of the motor to achieve braking torque signal feedback.

Abstract: The present invention relates to compounds and compositions for expanding the number of CD34+ cells for transplantation. The invention further relates to a cell population comprising expanded hematopoietic stem cells (HSCs) and its use in autologous or allogeneic transplantation for the treatment of patients with inherited immunodeficient and autoimmune diseases and diverse hematopoietic disorders to reconstitute the hematopoietic cell lineages and immune system defense.

Abstract: A method is provided for evaluating operational and financial performance for dispatchers in power grid control centers associated with utility systems. A comprehensive operating plan is provided that applies after the fact analysis for performance metrics, root-cause impacts and process re-engineering. after the fact analysis of past events and practices is performed. Actual system and resource conditions are captured. the system and resource conditions are supplied to a relational database. A scheduler engine receives the actual system and resource conditions from the relational database and processes it to calculate system performance.

Abstract: A phase current integration method for diagnosing a fault in a switched reluctance motor power converter determines whether the main switch of a switched reluctance motor power converter is experiencing a short circuit or an open circuit fault by measuring a phase current io(t) transient value of said converter in a non-fault state as well as a present phase current i(t) transient value of said converter, so as to obtain, by an integration operation, an integration value SnO of a phase current during a certain period under the non-fault state, and an integration value Sn of a phase current during a certain period under a present state, the ratio En of the two values indicating a fault characteristic value.

Abstract: Embodiments provide a network communication method, including obtaining, by a second convergence control apparatus after receiving an indication message sent by a first convergence control apparatus, a preset proportion of service data from service data that the first convergence control apparatus needs to transmit and performing, by the second convergence control apparatus, parameter matching on the preset proportion of service data according to a system parameter of a current communications standard The method also includes transmitting, by the second convergence control apparatus, the matched preset proportion of service data by using a corresponding data link layer. The embodiments further disclose a network communications apparatus.

Abstract: A machine for testing the parts and functions of a mobile phone includes a supporting mechanism, a platform, a receiving portion, and a detecting mechanism. The supporting mechanism is mounted in a box. The platform is slidably mounted on the supporting mechanism. The receiving portion is used to receive the mobile phone. The receiving portion is rotatably mounted on the platform. Devices within the machine are operated to test the mobile phone. A mobile phone testing system used in the testing machine is also described.

Abstract: Disclosed herein are novel compounds of formula (I) as described herein: and the use of such peptides in making immunoconjugates (i.e Antibody Drug Conjugates) Also described herein are immunoconjugates (i.e Antibody Drug Conjugates) comprising such novel compound linked to an antigen binding moiety, such as an antibody; where such immunoconjugates are useful for treating cell proliferative disorders. The invention further provides pharmaceutical compositions comprising these immunoconjugates, compositions comprising the immunoconjugates with a therapeutic co-agent, and methods to use these immunoconjugates and compositions for treating cell proliferation disorders.

Abstract: Provided herein are antibody conjugates comprising toll-like receptor agonists and the use of such conjugates for the treatment of cancer. In some embodiments, the conjugates comprise anti-HER2 antibodies.

Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.

Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.

Abstract: The present invention relates to the display technology field, and provides a backplate, a plastic-iron integrated structure, a backlight unit, and a display device. The backplate is provided with a first through hole, and the first through hole has an inner wall and an outer wall which form a projection structure on the backplate. When the backplate is bonded with a plastic frame to form the plastic-iron integrated structure, the plastic frame not only contacts the inner wall of the first through hole, but also contacts the surface of the projection structure, thus increasing the contact area between the plastic frame and the backplate, and increasing the bonding force between the plastic frame and the backplate. Even when the plastic frame shrinks in case of fluctuations in temperature and/or humidity, the plastic frame is not easily separated from the backplate, and the stability of the formed plastic-iron integrated structure is improved.

Abstract: The present invention relates to compounds and compositions for expanding the number of CD34+ cells for transplantation. The invention further relates to a cell population comprising expanded hematopoietic stem cells (HSCs) and its use in autologous or allogeneic transplantation for the treatment of patients with inherited immunodeficient and autoimmune diseases and diverse hematopoietic disorders to reconstitute the hematopoietic cell lineages and immune system defense.

Abstract: A decision-support tool is provided to evaluate operational and financial performance for dispatchers in power grid control centers associated with utility systems. A scheduler engine is coupled to a comprehensive operating plan that applies after the fact analysis for performance metrics, root-cause impacts and process re-engineering. A relational database is coupled to a data archiver that captures actual system and resource conditions and then supplies the system and resource conditions to the relational database. The scheduler engine receives the actual system and resource conditions from the relational database and processes it to calculate system performance.

Abstract: The present invention discloses a method for capturing drug targets, comprising the following steps of: (1) preparing row materials, i.e.

Abstract: Disclosed herein are novel cytotoxic peptides of formula (I) as described herein: and the use of such peptides in making immunoconjugates (i.e Antibody Drug Conjugates) Also described herein are immunoconjugates (i.e Antibody Drug Conjugates) comprising such novel cytotoxic peptide linked to an antigen binding moiety, such as an antibody; where such immunoconjugates are useful for treating cell proliferative disorders. The invention further provides pharmaceutical compositions comprising these immunoconjugates, compositions comprising the immunoconjugates with a therapeutic co-agent, and methods to use these immunoconjugates and compositions for treating cell proliferation disorders.

Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.

Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.